Timing of levosimendan in cardiac surgery

Anadolu Kardiyoloji Dergisi

Volumn 9, Issue 3, 2009, Pages 223-230

  Aksun, Murat ^a   Karahan, Nagihan ^a   Adanir, Tayfun ^a   Aran, Gülçin ^a   Yetkin, Ufuk ^a   Öztürk, Tülin ^a   Şencan, Atilla ^a   Özgürbüz, Uǧur ^a   Gürbüz, Ali ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cardiac surgery; Levosimendan; Low cardiac output

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; LACTIC ACID; LEVOSIMENDAN;

ADULT; ANESTHESIA INDUCTION; AORTA BALLOON; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE DYSFUNCTION; HIGH RISK PATIENT; HUMAN; INOTROPISM; LACTATE BLOOD LEVEL; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; URINE VOLUME;

AGED; CARDIAC OUTPUT, LOW; CARDIOTONIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMODYNAMICS; HUMANS; HYDRAZONES; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PATIENT SELECTION; POSTOPERATIVE CARE; PYRIDAZINES; RETROSPECTIVE STUDIES; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 69049101329     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Buket S, Engin C. Uc H. Cardiopulmonary bypass. In: Pac M, editor. Cardiac and vascular surgery. Ankara: MN Medical & Nobel Publishing; 2004. p 115-50 [Turkish].
2. Byrne JG, Smith WJ, Murphy MP, Couper GS, Appleyard RF, Cohn LH. Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion. J Thorac Cardiovasc Surg 1992; 104: 1589-96.
3. Shahzad GR, Benson SR. Levosimendan in cardiac surgery: current best available evidence. Ann Thorac Surg 2006; 81: 1536-46.
4. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007; 104: 766-73.
5. Antila S, Sundberg S, Lehtonen LA. Clinical pharmacology of levosimendan. Clin Pharmacokinet 2007; 46: 535-52.
6. Yokoshiki H, Katsube Y, Sunagawa N. Levosimendan, a novel Ca+2 sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 1997; 333: 249-59.
7. Labriola C, Brigiani MS, Carrata F. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Int J Clin Pharmacol Ther 2004; 42: 204-11.
8. Waris KS, Ylinen RS, Harjola VP. Levosimendan in cardiac surgery. J Cardiothorac Vasc Anesth 2005; 19: 345-9.
9. Parissis JT, Andreadou I, Bistola V, Paraskevaidis I, Filippatos G, Kremastinos DT. Novel biologic mechanisms of levosimendan and its effect on the failing heart. Expert Opin Investig Drugs 2008; 17: 1143-50.
10. Lehmann A, Boldt J, Lang J, Isgro F, Blome M. Is levosimendan an inoprotective drug in patients with acute coronary syndrome undergoing surgical revascularization? Anesthesiol Intensivemed Notfallmed Schmerzher; 2003; 38: 577-82.
11. Avery GJ, Ley SJ, Hill JD, Hershon JJ, Dick SE. Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome. Ann Thorac Surg 2001; 71: 591-6.
12. Ascione R, Narayan P, Rogers CA, Lim KH, Capoun R, Angelini GD. Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg 2003; 76: 793-9.
13. Müller M, Junger A, Bräu M, Kwapisz MM, Schindler E, Akintürk H, et al. Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anesthesia record-keeping system. Br J Anaesth 2002; 89: 398-4.
14. Rao V, Ivanow J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996; 112: 38-51.
15. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden IB, et al. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995; 27: 1859-66.
16. Levijoki JL, Pollesello P, Kaivola J, Tilgmann C, Sorsa T, Annila A, et al. Furter evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan. J Mol Cell Cardiol 2000; 32: 479-91.
17. Pollesello P, Ovaska M, Kaivola J, Tilgmann C, Lundström K, Kalkkinen N, et al. Binding of a new Ca+2 sensitizer, levosimendan, to recombinant cardiac troponin C: a molecular modeling, fluorescence probe and proton nuclear magnetic resonance study. J Biol Chem 1994; 269: 28584-90.
18. Parissis JT, Farmakis D, Nieminen M. Classical inotropes and new cardiac enhancers. Heart Fail Rev 2007; 12: 149-56.
19. Figgitt DP, Gillies PS, Goa KL. Levosimendan. Drugs 2001; 61: 613-27.
20. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet 2002; 360: 196-2.
21. Malliotakis P, Xenikakis T, Linardakis M, Hassoulas J. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series. Hellenic J Cardiol 2007; 48: 80-8.
22. Rajek AM, Koining H, Jelen M, Schiferer A, Hutschala D. Levosimendan, a new Ca-sensitizer in patients with poor left ventricular function undergoing cardiac surgery. Anesthesiology 2003; 99: 133 A.
23. Lehmann A, Lang J, Boldt J, Isgro F, Kiessling AH. Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series. 2004; Med Sci Monit 10: 89-93.
24. Eriksson H, Jalonen J, Heikkinen L, Kivikko M, Laine M, Leino K, et al. Levosimendan enhances weaning from cardiopulmonary bypass in patients with compromised heart function after coronary artery bypass graft surgery. Society of cardiovascular anesthesiologist. 29th annual meeting, 2007 Montreal, Canada. Anesth Analg. Supplement 2007; 104: 1-123.
25. Tasouli A, Papadopoulos K, Antoniou T, Kriaras I, Stavridis G, Degiannis D, et al. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg. 2007; 32: 629-33.